What does this research mean for the field?

The 2025 ATAGI Annual Statement outlines the key successes, trends, and challenges in Australian vaccine use and vaccine-preventable disease control in 2024, and establishes priority recommendations for 2025. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This statement aims to summarize the current status of immunization and address future priorities.

May 28, 2026Communicable Diseases Intelligence0 citationsOpen Access

ATAGI 2025 Annual Statement on Immunisation

KNKatrina NicolopoulosChildren's Hospital at Westmead SKSaskia van der KooiNational Centre for Immunisation Research & Surveillance CCClayton ChiuNational Centre for Immunisation Research & Surveillance

Key Points

This statement aims to summarize the current status of immunization and address future priorities.
Annual review of vaccine usage and impact in Australia for 2024
Identification of key successes, trends, and challenges in immunization
Formulation of priority actions for 2025 and beyond
Highlights successes in reducing vaccine preventable diseases in Australia.
Identifies ongoing challenges in vaccine uptake and public health responses.
Recommends strategic actions to enhance immunization efforts moving forward.

Abstract

The Australian Technical Advisory Group on Immunisation (ATAGI) 2025 Annual Statement on Immunisation is the fifth publication in this series. It highlights the key successes, trends and challenges in the use of vaccines and control of vaccine preventable diseases (VPDs) in Australia in 2024. It also signals ATAGI's priority advice on actions to address key issues for 2025 and beyond.

Perguntar à IA

Bookmark

View Full Paper